A Retrospective Study on Novel Oral Anticoagulants (NOACs) as Secondary Prevention of Thromboembolic Stroke in Patients with Nonvalvular Atrial Fibrillation

被引:0
|
作者
Hayes, E.
Ng, J.
Moffatt, U.
McInerney, A.
Kelleher, B.
Hickey, P.
机构
[1] Sligo Reg Hosp, Dept Med, Sligo, Ireland
[2] Intern Network West Northwest, Limerick, Ireland
关键词
WARFARIN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:274 / 274
页数:1
相关论文
共 50 条
  • [1] Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Deitelzweig, Steven
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 74 - 81
  • [2] Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
    Lin, Yi-Pin
    Tan, Teng-Yeow
    MEDICINE, 2015, 94 (38)
  • [3] Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation
    Oertel, Lynn B.
    Fogerty, Annemarie E.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2017, 29 (09) : 551 - 561
  • [4] The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation
    Kuznetsov, Sofya
    Barcelona, Robert
    Josephson, Richard A.
    Mohan, Sri K. Madan
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (05)
  • [5] The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation
    Sofya Kuznetsov
    Robert Barcelona
    Richard A. Josephson
    Sri K. Madan Mohan
    Current Neurology and Neuroscience Reports, 2016, 16
  • [6] INDIRECT COMPARISONS OF NOVEL ORAL ANTICOAGULANTS FOR THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: A SYSTEMATIC LITERATURE REVIEW
    Claflin, A. B.
    Liu, X.
    Phatak, H.
    VALUE IN HEALTH, 2013, 16 (07) : A514 - A515
  • [7] Novel oral anticoagulants for stroke prevention in atrial fibrillation
    Taylor, Jennifer
    EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1419 - 1420
  • [8] Cost-effectiveness of apixaban against other novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation patients
    Lip, G. H. Y.
    Kongnakorn, T.
    Phatak, H.
    Kuznik, A.
    Rublee, D.
    Lanitis, T.
    Liu, L.
    Iloeje, U.
    Dorian, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 54 - 54
  • [9] Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
    Dobesh, Paul P.
    Fanikos, John
    DRUGS, 2015, 75 (14) : 1627 - 1644
  • [10] COMPARATIVE EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Owen, R. K.
    Morris, J.
    Le Reun, C.
    Mughal, F.
    VALUE IN HEALTH, 2020, 23 : S503 - S503